Vida Ventures related stories
All articles and analysis
Allogene Therapeutics grabs funding from Vida VenturesSouth San Francisco-based Allogene Therapeutics, a biotech company focused on cancer treatment, has secured an undisclosed amount of funding. The investor was Vida Ventures.
- Pionyr Immunotherapeutics racks up $62 mln Series B
Pionyr Immunotherapeutics Inc, a developer of antibody therapeutics, has raised $62 million in Series B funding. New Enterprise Associates led the round with participation from other investors that included Sofinnova Ventures, Vida Ventures, OrbiMed, SV Health Investors, Osage University Partners and Mission Bay Ventures.
- Vida Ventures raises $254.8 mln venture capital fund
Vida Ventures has raised a $254.8 million venture capital fund, according to a filing with the SEC.
- Homology Medicines racks up $83.5 mln Series B
Bedford, Massachusetts-based Homology Medicines Inc, a genetic medicines company, has raised $83.5 million in Series B financing. Deerfield Management led the round with participation from Fidelity Management and Research Company, HBM Healthcare Investments, Maverick Ventures, Novartis, Rock Springs Capital, Vida Ventures, Vivo Capital, Alexandria Venture Investments, 5AM Ventures, ARCH Venture Partners and Temasek.